IMPURITIES AVAILABLE FOR 'Plerixafor'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Plerixafor. Plerixafor is a hematopoietic stem cell mobilizer used in combination with granulocyte-colony stimulating factor (G-CSF) to enhance the collection of stem cells for autologous transplantation in patients with non-Hodgkin’s lymphoma and multiple myeloma. It works by selectively antagonizing the CXCR4 chemokine receptor, disrupting the interaction with stromal cell-derived factor-1α (SDF-1α), which normally retains stem cells in the bone marrow. This action causes stem cells to move into the bloodstream for easier collection via apheresis. Plerixafor is administered via subcutaneous injection and is generally well tolerated. Common side effects include injection site reactions, gastrointestinal discomfort, dizziness, and headache. It significantly improves stem cell yield, especially in patients who respond poorly to G-CSF alone. Regular blood monitoring is required to determine optimal timing for apheresis. Buy high quality Plerixafor from Omsynth Lifesciences.